TrialPloS one2013

Phase 2a study of ataluren-mediated dystrophin production in patients with nonsense mutation Duchenne muscular dystrophy.

Richard S Finkel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.